CMR Surgical

Surgical robotics company whose modular Versius system, and its second-generation Versius Plus, are used for minimal access surgery.

cmrsurgical.com

At a glance

Headquarters: Cambridge, United Kingdom
Founded: 2014
Business model: B2B
Products profiled: 1
Operating markets: United Kingdom, United States
Sources cited: 5
In the library since: 24 September 2026

What it does

CMR Surgical makes the Versius surgical robotic system and its second generation, Versius Plus, which the company describes as designed to mimic the human arm and approved for use across Europe, Australia and Brazil.

Independent evidence

Established from a source other than the company.

Companies House records CMR SURGICAL LIMITED (company number 08863657), formerly Cambridge Medical Robotics Limited, with its registered office in Cambridge. The FDA granted the De Novo DEN230078 for the Versius Surgical System on 11 October 2024 and cleared Versius Plus under 510(k) K252111 on 16 December 2025, product code SCV.

What the company says

The company’s own statements, attributed to it and not presented as established fact.

In March 2026 the company said more than 45,000 patients worldwide had been treated with Versius, that it was used in more than 30 countries, that it was the second most widely used robotic surgery platform globally, and that it was making its formal introduction to US surgeons.